Hungary approves China's Sinopharm COVID-19 vaccine

Source: Xinhua| 2021-01-30 01:08:19|Editor: huaxia

BUDAPEST, Jan. 29 (Xinhua) -- Hungary authorized the use of China's Sinopharm COVID-19 vaccine, Hungarian Chief Medical Officer Cecilia Muller said on Friday.

"Today the National Institute of Pharmacy and Nutrition gave its approval for the Sinopharm vaccine," Muller told a briefing.

Besides the Pfizer-BioNTech and Moderna vaccines acquired through the European Union, Hungary has also approved Russia's Sputnik V and the British AstraZeneca COVID-19 vaccines.

As the world is struggling to contain the pandemic, vaccination is underway in some countries with the already-authorized coronavirus vaccines.

Meanwhile, 236 candidate vaccines are still being developed worldwide -- 63 of them in clinical trials -- in countries including Germany, China, Russia, Britain and the United States, according to information released by the World Health Organization on Tuesday. Enditem

KEY WORDS:
EXPLORE XINHUANET
010020070750000000000000011100001397079961